|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-2-6
|
|
pubmed:abstractText |
The hypothesis that sentinel lymph node (SLN) mapping in breast cancer patients is optimized by combining blue dye and isotope is reasonable and intuitive. Despite this, few studies examine in detail the factors contributing to the success of these techniques, either individually or in combination.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1068-9265
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
8
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
13-9
|
|
pubmed:dateRevised |
2007-7-18
|
|
pubmed:meshHeading |
pubmed-meshheading:11206218-Breast Neoplasms,
pubmed-meshheading:11206218-Coloring Agents,
pubmed-meshheading:11206218-Diagnosis, Differential,
pubmed-meshheading:11206218-Female,
pubmed-meshheading:11206218-Humans,
pubmed-meshheading:11206218-Injections, Intralesional,
pubmed-meshheading:11206218-Injections, Subcutaneous,
pubmed-meshheading:11206218-Lymph Node Excision,
pubmed-meshheading:11206218-Lymph Nodes,
pubmed-meshheading:11206218-Lymphatic Metastasis,
pubmed-meshheading:11206218-Middle Aged,
pubmed-meshheading:11206218-Multivariate Analysis,
pubmed-meshheading:11206218-Predictive Value of Tests,
pubmed-meshheading:11206218-Radiopharmaceuticals,
pubmed-meshheading:11206218-Rosaniline Dyes,
pubmed-meshheading:11206218-Sentinel Lymph Node Biopsy,
pubmed-meshheading:11206218-Technetium Tc 99m Sulfur Colloid
|
|
pubmed:articleTitle |
Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures.
|
|
pubmed:affiliation |
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. codyh@mskcc.org
|
|
pubmed:publicationType |
Journal Article
|
